UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013329 |
|---|---|
| Receipt number | R000015553 |
| Scientific Title | Phase2 study of Carboplatin / Nab-paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussion |
| Date of disclosure of the study information | 2014/03/05 |
| Last modified on | 2021/01/25 18:24:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/03/04 13:13:28 | ||
| 2 | Update | 2014/04/17 20:22:28 | Recruitment status |
|
| 3 | Update | 2014/04/17 20:23:26 | Co-sponsor |
|
| 4 | Update | 2016/06/16 15:35:11 | Name of primary person or sponsor Organization Co-sponsor |
|
| 5 | Update | 2016/06/16 15:37:20 | Last follow-up date |
|
| 6 | Update | 2021/01/25 18:24:30 | Recruitment status Date of IRB |
